Last updated: 2026-10-16 12:06:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Heartflow, Inc. (HTFL) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $51.23, with a market capitalization of $4.30B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $20.13 to $54.32. This page covers its latest market performance, valuation, price trends and company information.
$4.30B | |
$52.00 | |
$54.32 | |
$20.13 | |
$50.91 | |
171.00 | |
1.83M | |
-- | |
$54.32 | |
$20.13 | |
-- | |
-- |
Heartflow, Inc. (HTFL) is trading at $51.23 in pre-market trading as of 2026-10-16 12:01:00, up 0.64% ($0.33) from the previous close of $50.91
Pre-market trading shows how investors are pricing HTFL before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Heartflow, Inc. (HTFL) moved from $49.36 to $51.23, representing a gain of 3.79% ($1.87).
The stock traded between $46.50 and $52.00 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 1.47 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 91.0%
HTFL is currently trading at $51.23, placing it 91.0% of the way from its 52-week low of $20.13 to its 52-week high of $54.32. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 843 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Heartflow, Inc. (HTFL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.